The Congressional Stock Trading Ban: Where the Legislation Stands in 2026

Polling consistently shows that 67–78% of Americans support banning members of Congress from trading individual stocks. Multiple bipartisan bills have been introduced with significant co-sponsor support. The House has passed reform legislation twice.

As of 2026, there is still no ban.

Here's the full story of where the legislation stands, why it keeps stalling, and what a ban would actually mean.

The Bills on the Table

Several distinct pieces of legislation have targeted congressional stock trading over the past few years:

TRUST in Congress Act

Sponsors: Multiple bipartisan sponsors in both chambers What it does: Requires members of Congress and their spouses to place holdings in qualified blind trusts managed by independent trustees. Members would not know what's in the trust or what trades are being made. Status: Has passed the House. Has stalled repeatedly in the Senate, where a small number of members with large trading portfolios have blocked or slowed floor votes.

ETHICS Act (Ban Congressional Stock Trading Act)

Sponsors: Bipartisan — includes both progressive Democrats and libertarian-leaning Republicans What it does: Outright ban on individual stock ownership by members of Congress, their spouses, and dependent children. Would require divestiture within 180 days of taking office. Status: Has not passed either chamber. More aggressive than the blind trust approach and faces more resistance.

STOCK Act 2.0 / Enhanced STOCK Act

Various sponsors What it does: Strengthens the existing STOCK Act — shortens disclosure window from 45 days to 24–48 hours, dramatically increases fines ($10,000–$50,000 per violation vs. the current $200), and requires automated brokerage reporting tied directly to congressional payroll systems. Status: Has not passed. The fine increase would make the current compliance culture untenable.

The Arguments For a Ban

Information asymmetry is structural: Committee members receive classified briefings, advance legislative text, and closed-door industry testimony that retail investors cannot access. Trading in the same sectors they oversee creates an inherent asymmetry that no disclosure requirement fully addresses.

Public trust: Polling is unambiguous — voters across both parties believe members of Congress shouldn't be able to trade stocks. The perceived conflict of interest undermines confidence in legislative decisions regardless of whether any specific trade is actually information-driven.

Legislative incentives: A member who holds significant positions in healthcare stocks has a financial interest in how drug pricing legislation resolves. Whether or not they consciously let that interest affect their vote, the structural conflict exists. Blind trusts or full divestiture remove that conflict.

Enforcement failure: The STOCK Act's prohibition on legislative MNPI trading is effectively unenforceable, as the near-zero prosecution record demonstrates. If the law can't be enforced, removing the underlying conflict (the ability to trade) is the only practical remedy.

The Arguments Against a Ban

Recruitment: Critics argue that banning stock ownership would deter successful professionals from running for Congress, reducing the talent pool. Counter-argument: the overwhelming majority of countries with functioning democracies impose stricter trading restrictions on legislators than the US does.

Constitutional concerns: Some members have raised First and Fifth Amendment arguments about requiring divestiture. Legal scholars are largely skeptical — courts have upheld far more intrusive conditions on federal employment.

Financial hardship: For members with significant portfolios, forced divestiture could create substantial capital gains tax liabilities. Several proposals include provisions for tax-deferred treatment of forced divestitures to address this.

Effective already: Some members argue the STOCK Act already prohibits the problematic behavior (trading on MNPI) and that a blanket ban goes further than necessary. The enforcement record makes this argument difficult to sustain.

Why It Keeps Failing

The structural explanation is simple: the members who must vote for reform are the members whose trading it would restrict.

The most active congressional traders — members with the most to lose from a ban — have outsized influence on whether reform legislation reaches the floor. Senate Majority and Minority Leaders control the Senate schedule. Committee chairs control the House committee calendar. Members with large trading portfolios tend to be senior, well-funded, and well-connected.

The 2022 moment came closest. Public outrage from the COVID trades (Burr, Loeffler, Perdue) combined with renewed attention to Pelosi trades created genuine political pressure. The House passed a version of the TRUST in Congress Act. It died in the Senate.

The 2024 cycle saw another round of reform momentum, another round of stalling.

Each time reform fails, trading continues. Each time a high-profile trade becomes public, reform momentum builds. The cycle has been stable for years.

What a Ban Would Mean for Cloakroom Users

If Congress passed a comprehensive ban on individual stock trading, what would change?

What would disappear: Individual stock picks by members — the specific trade signals that generate high intent scores. Committee-adjacent sector plays. The information-driven trades that drive the most attention.

What would remain: ETF trades are typically exempt from proposed bans (too broadly diversified to be information-adjacent). Blind trust activity wouldn't be disclosed. Crypto holdings are a grey area in most proposals. The whale tracker (institutional 13F filings) would be entirely unaffected.

The honest assessment: A meaningful ban with real enforcement would reduce the quality of the congressional trading signal. That's a feature, not a bug — it would mean the underlying problem of information asymmetry had been addressed.

Until that happens, the signal exists and is worth tracking.

The Current Status (2026)

No comprehensive congressional trading ban has passed as of mid-2026. The most recent reform push introduced in the 119th Congress has the same structural obstacles as previous attempts.

The probability of passage in any given Congress is low. The probability of eventual passage, given sustained public pressure and recurring high-profile trading controversies, is higher than it's been at any point since 2012.

Until a ban passes — and possibly even after — Cloakroom tracks every disclosure in real time. If a ban does pass, we'll adapt the platform to whatever signal remains.

---

This post is informational. Cloakroom does not take a position on congressional trading reform legislation.